Financhill
Back

Harmony Biosciences Holdings Quote, Financials, Valuation and Earnings

9,530x the last time this happened

Here's what our expert says you should buy before April 14.
Sell
10

HRMY
Harmony Biosciences Holdings

Last Price:
29.30
Seasonality Move:
4.86%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Harmony Biosciences Holdings Price Quote

$29.30
-0.02 (1.28%)
(Updated: April 27, 2024 at 6:07 AM ET)

Harmony Biosciences Holdings Key Stats

Sell
10
Harmony Biosciences Holdings (HRMY) is a Sell

Day range:
$29.00 - $30.14
52-week range:
$18.61 - $39.27
Dividend yield:
0%
P/E ratio:
13.77
P/S ratio:
3.04
P/B ratio:
3.56%

Volume:
375.9K
Avg. volume:
408.6K
1-year change:
-7.45%
Market cap:
$1.7B
Revenue:
$582M
EPS:
$2.12

How Much Does Harmony Biosciences Holdings Make?

Is Harmony Biosciences Holdings Growing As A Company?

Harmony Biosciences Holdings Stock Price Performance

What Is Harmony Biosciences Holdings 52-Week High & Low?

Harmony Biosciences Holdings Price To Free Cash Flow

Is It Risky To Buy Harmony Biosciences Holdings?

Is Harmony Biosciences Holdings Cash Flow Positive?

  • What Is HRMY Cash Flow From Operations?
    Cash flow from operations (TTM) is $219.4M
  • What Is Harmony Biosciences Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$105.6M
  • What Is Harmony Biosciences Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$46.4M

Harmony Biosciences Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    HRMY return on invested capital is 19.86%
  • What Is Harmony Biosciences Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is 17.23%
  • What Is HRMY Return On Equity?
    ROE is a measure of profitability and is 28.27%

Harmony Biosciences Holdings Earnings Date & Stock Price

Harmony Biosciences Holdings Competitors

Harmony Biosciences Holdings Dividend Yield

Data Unavailable

Harmony Biosciences Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: -43.04% -20.07%
Revenue: 31.26% 0.09%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 41.50
Upside from Last Price: 41.54%

Major Shareholders

  • How many HRMY shares are owned by institutional investors?
    70.3M HRMY shares are owned by institutional investors
  • How many HRMY shares are owned by insiders?
    267.5K HRMY shares are owned by insiders